Pancreatic Cancer Research

ResearcherSun Yat-sen University Cancer CenterNo recent work listed

Guo-Kai Feng

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-8251-291X; OpenAlex author ID A5016236030.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
3
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 2

  1. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.3c00321↗
  2. An optimized integrin α6-targeted peptide for positron emission tomography/magnetic resonance imaging of pancreatic cancer and its precancerous lesion. Last author DOI 10.1002/ctm2.157↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Chunjing Yu · 1 shared paper, 2023
  2. Liping Chen · 1 shared paper, 2023
  3. Yan Mei · 1 shared paper, 2020

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.